⚖️ Drug Manufacturers - General

Industry peer comparison — 5 companies ranked by market cap. Click any column header to sort; click a symbol for its full fundamentals page.

AI-assisted data: figures are extracted from public quarterly filings with AI assistance, under human editorial oversight, and may still contain errors — verify against official filings. Educational information only, not financial advice.
# Company CMP (₹) MCap (Cr) P/E Sales TTM (Cr) NP TTM (Cr) OPM % NPM % Sales YoY % NP YoY % Qtr Rev Δ% Qtr NP Δ%
1 GLAXO GlaxoSmithKline Pharmaceuticals 2,818.90 47,754 44.7 3,955 1,068 40.8% 27.0% 1.9% 11.6% 16.6% 15.7%
2 RUBICON RUBICON RESEARCH 1,839.40 30,367 103.7 1,936 288 23.3% 14.9% — — 51.8% 97.2%
3 PFIZER Pfizer 4,055.00 18,551 25.2 2,569 735 36.7% 28.6% 10.4% -5.8% 8.3% 6.2%
4 SAIPARENT Sai Parenterals 498.00 2,200 — — — — — — — 435.1% 458.0%
5 SYMBIOTEC Symbiotec Pharmalab 1,107.00 — — — — — — — — 7.5% -53.1%
TTM = trailing twelve months. Banks/NBFCs show total income in the sales column. Live prices refresh about twice a day. Educational information only — not financial advice.
⚠️ How this site is made: Market data pages are computed automatically from NSE/BSE publications and company filings; news articles and announcement analyses are written with AI assistance, with a human in the loop: our editors review what the AI produces. Both can contain errors. Verify with the original sources before any investment decision. Not investment advice; Flash Finance is not SEBI-registered. How we use AI